Lifemd, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ

11 Mar 2025

LFMD

10-K: LifeMD's 2024 10-K Filing Reveals 39% Revenue Growth, Strategic Pharmacy Launch, and Focus on Telehealth Expansion

LifeMD's 2024 10-K filing highlights a 39% increase in revenue, driven by telehealth services, and details strategic initiatives including the launch of a wholly-owned pharmacy and expansion into commercial insurance.

NASDAQ

11 Mar 2024

LFMD

Lifemd, INC

10-K: LifeMD, Inc. Reports 28% Revenue Growth in 2023, Driven by Telehealth and WorkSimpli

LifeMD, Inc. experienced a 28% increase in total revenue in 2023, fueled by growth in both its telehealth and WorkSimpli segments.